查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
家禽疫苗市场-全球市场规模、份额、趋势分析、机会和预测报告，2019-2029
市场调查报告书
商品编码
1334463

家禽疫苗市场-全球市场规模、份额、趋势分析、机会和预测报告，2019-2029

Poultry Vaccines Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Product Type ; By Dosage Form ; By Disease Type ; By Application ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2029年全球家禽疫苗市场规模将达39亿美元

由于市场参与者的技术进步以及与家禽疫苗相关的研发活动的增加，全球家禽疫苗市场正在蓬勃发展。

领先的战略咨询和市场研究公司 BlueWeave Consulting 最近的一项研究估计，2022 年全球家禽疫苗市场规模为 27.63 亿美元。 BlueWeave预测，在2023-2029年预测期内，全球家禽疫苗市场规模将以5.7%的复合年复合成长率显着增长，到2029年达到38.57亿美元。全球家禽疫苗市场的主要增长促进因素包括家禽产量的增加、对家禽产品的需求增加以及人们对疫苗接种在疾病预防中的重要性的认识不断提高。家禽数量的增加和禽病患病率的增加预计将进一步增加对家禽疫苗的需求。疫苗接种在疾病预防中发挥着重要作用，可以降低与食用受感染肉类相关的风险以及家禽养殖场面临的挑战。 2019年，美国鸡数量为1972万隻，巴西鸡数量为1460万隻，这凸显出大量易感鸟类可以从及时疫苗接种中受益。根据OIE-WAHIS数据库，特定时期内新发禽类疫情的数量仅为22起，但2020年跃升至836起，估计达到279万例。该禽类疾病爆发的显着增加是家禽疫苗市场的主要促进因素。然而，在分析期间，家禽疫苗的副作用、成本高、获取有限等预计将抑制整体市场的增长。

该报告的详细分析提供了有关全球家禽疫苗市场的增长潜力、未来趋势和统计数据的信息。它还涵盖了推动市场总规模预测的因素。该报告致力于为决策者提供全球家禽疫苗市场的最新技术趋势以及行业见解，以做出明智的战略决策。它还分析了市场的增长促进因素、挑战和竞争力。

目录

第1章研究框架

第2章执行摘要

第3章全球家禽疫苗市场洞察

  • 行业价值链分析
  • DROC分析
    • 增长促进因素
      • 增加与家禽疫苗相关的研究活动
      • 市场相关人员的重大技术进步
    • 抑制因素
      • 家禽疫苗的副作用
      • 成本高且访问受限
    • 机会
      • 禽流感疫情
      • 灭活疫苗的使用增加
    • 任务
      • 疾病抗原变异
      • 冷链管理
  • 技术进步/最新发展
  • 法律规范
  • 波特五力分析

第4章全球家禽疫苗市场概况

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 按产品类型
      • 减毒活疫苗
      • 灭活疫苗
      • 亚单位疫苗
      • DNA疫苗
      • 重组疫苗
    • 按剂型分
      • 液体疫苗
      • 冻干疫苗
      • 管
    • 按疾病类型
      • 传染性支气管炎
      • 传染性法氏囊病
      • 传染性喉气管炎
      • 丢蛋综合征
      • 腺病毒
      • 鸭病毒性肠炎
      • 包涵体肝炎
      • 球虫病
      • 禽流感
      • 马立克氏病
      • 新城疫
      • 沙门氏菌
      • 禽脑脊髓炎
      • 家禽霍乱
    • 按用途
      • 肉鸡
      • 层
      • 饲养员
    • 按地区
      • 北美
      • 欧洲
      • 亚太地区 (APAC)
      • 拉丁美洲 (LATAM)
      • 中东和非洲 (MEA)

第5章北美家禽疫苗市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 按产品类型
    • 按剂型分
    • 按疾病类型
    • 按用途
    • 按国家/地区
      • 美国
      • 加拿大

第6章欧洲家禽疫苗市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 按产品类型
    • 按剂型分
    • 按疾病类型
    • 按用途
    • 按国家/地区
      • 德国
      • 英国
      • 意大利
      • 法国
      • 西班牙
      • 比利时
      • 俄罗斯
      • 荷兰
      • 其他欧洲国家

第7章亚太地区家禽疫苗市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 按产品类型
    • 按剂型分
    • 按疾病类型
    • 按用途
    • 按国家/地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳大利亚和新西兰
      • 印尼
      • 马来西亚
      • 新加坡
      • 越南
      • 亚太地区其他地区

第8章拉美家禽疫苗市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 按产品类型
    • 按剂型分
    • 按疾病类型
    • 按用途
    • 按国家/地区
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘鲁
      • 拉丁美洲其他地区

第9章中东及非洲家禽疫苗市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 按产品类型
    • 按剂型分
    • 按疾病类型
    • 按用途
    • 按国家/地区
      • 沙特阿拉伯
      • 阿拉伯联合酋长国
      • 卡塔尔
      • 科威特
      • 南非
      • 尼日利亚
      • 阿尔及利亚
      • MEA 的其余部分

第10章竞争格局

  • 主要企业及其产品列表
  • 2022年全球家禽疫苗市场份额分析
  • 通过运行参数进行竞争基准测试
  • 主要战略发展（合併、收购、合作伙伴关係等）

第11章COVID-19对全球家禽疫苗市场的影响

第12章公司简介（公司简介、财务矩阵、竞争格局、关键人才、主要竞争、联繫地址、战略展望、SWOT分析）

  • Boehringer Ingelheim International GmbH
  • Ceva
  • Zoetis
  • Elanco
  • Merck & Co., Inc.
  • Hester Biosciences Limited
  • Vaxxinova International BV
  • Venkys India
  • Calier
  • KM Biologics
  • Phibro Animal Health Corporation
  • Other Prominent Players

第13章关键战略建议

第14章调查方法

  • 定性研究
    • 初级和次级研究
  • 定量研究
  • 市场细分和资料三角测量
    • 二次调查
    • 初步调查
  • 主要调查受访者的地区分布
  • 假设和限制
简介目录
Product Code: BWC23648

Global Poultry Vaccines Market Size Set to Touch USD 3.9 Billion by 2029.

Global poultry vaccines market is flourishing because of the rising technological advancements by market players and increasing R&D activities associated with poultry vaccines.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global poultry vaccines market size at USD 2.763 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global poultry vaccines market size to grow at a significant CAGR of 5.7% reaching a value of USD 3.857 billion by 2029. Major growth drivers for the global poultry vaccines market include an increasing poultry production, rising demand for poultry products, and growing awareness about the importance of vaccination in disease prevention. The expanding poultry population and the increasing prevalence of avian diseases are expected to further drive the demand for poultry vaccines. To mitigate the risks associated with infected meat consumption and the challenges faced by poultry farms, vaccination plays a crucial role in disease prevention. In 2019, the United States had 19.72 million livestock units of chickens, while Brazil had 14.6 million livestock units, highlighting the considerable number of susceptible birds that could benefit from timely vaccinations. According to the OIE-WAHIS database, there were only 22 new bird outbreaks within a specific period, but this number drastically surged to 836 outbreaks in 2020, with an estimated 2.79 million cases. This significant rise in disease outbreaks among the avian population serves as a key driver for the poultry vaccines market. However, side-effects of poultry vaccines and high costs and limited access are anticipated to restrain the overall market growth during the period in analysis.

Global Poultry Vaccines Market - Overview:

The global poultry vaccines market refers to the worldwide market for vaccines specifically developed for poultry species. Poultry vaccines are used to prevent and control various diseases that affect poultry, including viral, bacterial, and parasitic infections. The market encompasses the research, development, production, and distribution of these vaccines. It plays a crucial role in maintaining the health and productivity of poultry populations, supporting the sustainable growth of the poultry industry. The global poultry vaccines market is driven by increasing poultry production, rising demand for poultry products, and growing awareness of the importance of vaccination in disease prevention.

Impact of COVID-19 on Global Poultry Vaccines Market:

COVID-19 pandemic had a mixed impact on the global poultry vaccines market. On the one hand, there was an increased focus on food safety and biosecurity, which heightened the importance of disease prevention measures, including vaccination, leading to a surge in demand for poultry vaccines. On the other hand, disruptions in the supply chain, restrictions on international trade, and reduced poultry production in some regions posed challenges to the market. Additionally, the diversion of resources toward human health during the pandemic affected R&D activities in the field.

Global Poultry Vaccines Market - By Application:

Based on application, the global poultry vaccines market is divided into Broiler, Layer, and Breeder segments. The breeder segment held the highest market share in 2022 by application due to the increasing number of breeder farms that produce fertile eggs for hatcheries. The enhanced productivity achieved through these breeding farms has greatly contributed to the market's expansion. Government initiatives aimed at vaccinating breeders have played a significant role in driving market growth. Vaccinating breeders not only safeguards the vaccinated birds but also protects the progeny, including broilers. Proactive government policies have resulted in the growth of poultry farmers, breeders, integrators, and feed mills. For example, the Animal Husbandry Department in the state of Andhra Pradesh, India implemented a comprehensive poultry development policy (2016-2020), stimulating production in the poultry sector, promoting egg and chicken processing, and facilitating export activities. Such favorable government initiatives continue to propel the market's growth. Additionally, the market benefits from a favorable regulatory environment and supportive measures that promote sustainable poultry farming practices and ensure food security.

Competitive Landscape:

Major players operating in the global poultry vaccines market include: Boehringer Ingelheim International GmbH, Ceva, Zoetis, Elanco, Merck & Co., Inc., Hester Biosciences Limited, Vaxxinova International BV, Venkys India, Calier, KM Biologics, and Phibro Animal Health Corporation. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Poultry Vaccines Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Poultry Vaccines Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Poultry Vaccines Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing Research Activities Associated with Poultry vaccines
      • 3.2.1.2. Huge Technological Advancements by Market Players
    • 3.2.2. Restraints
      • 3.2.2.1. Side-Effects of Poultry Vaccines
      • 3.2.2.2. High Costs and Limited Access
    • 3.2.3. Opportunities
      • 3.2.3.1. Increasing Prevalence of Avian Influenza
      • 3.2.3.2. Increasing Usage of Inactivated Vaccines
    • 3.2.4. Challenges
      • 3.2.4.1. Antigenic Variation of Diseases
      • 3.2.4.2. Cold Chain Management
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Poultry Vaccines Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Billion)
  • 4.2. Market Share and Forecast
    • 4.2.1. By Product Type
      • 4.2.1.1. Attenuated Live Vaccines
      • 4.2.1.2. Inactivated Vaccines
      • 4.2.1.3. Subunit Vaccines
      • 4.2.1.4. DNA Vaccines
      • 4.2.1.5. Recombinant Vaccines
    • 4.2.2. By Dosage Form
      • 4.2.2.1. Liquid Vaccine
      • 4.2.2.2. Freeze Dried Vaccine
      • 4.2.2.3. Duct
    • 4.2.3. By Disease Type
      • 4.2.3.1. Infectious Bronchitis
      • 4.2.3.2. Infectious Bursal Diseases
      • 4.2.3.3. Infectious Laryngotracheitis
      • 4.2.3.4. Egg Drop Syndrome
      • 4.2.3.5. Adenovirus
      • 4.2.3.6. Duck Viral Enteritis
      • 4.2.3.7. Inclusion Body Hepatitis
      • 4.2.3.8. Coccidiosis
      • 4.2.3.9. Avian Influenza
      • 4.2.3.10. Marek's Disease
      • 4.2.3.11. Newcastle Disease
      • 4.2.3.12. Salmonella
      • 4.2.3.13. Avian Encephalomyelitis
      • 4.2.3.14. Fowl Cholera
    • 4.2.4. By Application
      • 4.2.4.1. Broiler
      • 4.2.4.2. Layer
      • 4.2.4.3. Breeder
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia Pacific (APAC)
      • 4.2.5.4. Latin America (LATAM)
      • 4.2.5.5. Middle East and Africa (MEA)

5. North America Poultry Vaccines Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Billion)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type
    • 5.2.2. By Dosage Form
    • 5.2.3. By Disease Type
    • 5.2.4. By Application
    • 5.2.5. By Country
      • 5.2.5.1. United States
      • 5.2.5.1.1. By Product Type
      • 5.2.5.1.2. By Dosage Form
      • 5.2.5.1.3. By Disease Type
      • 5.2.5.1.4. By Application
      • 5.2.5.2. Canada
      • 5.2.5.2.1. By Product Type
      • 5.2.5.2.2. By Dosage Form
      • 5.2.5.2.3. By Disease Type
      • 5.2.5.2.4. By Application

6. Europe Poultry Vaccines Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Billion)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Dosage Form
    • 6.2.3. By Disease Type
    • 6.2.4. By Application
    • 6.2.5. By Country
      • 6.2.5.1. Germany
      • 6.2.5.1.1. By Product Type
      • 6.2.5.1.2. By Dosage Form
      • 6.2.5.1.3. By Disease Type
      • 6.2.5.1.4. By Application
      • 6.2.5.2. United Kingdom
      • 6.2.5.2.1. By Product Type
      • 6.2.5.2.2. By Dosage Form
      • 6.2.5.2.3. By Disease Type
      • 6.2.5.2.4. By Application
      • 6.2.5.3. Italy
      • 6.2.5.3.1. By Product Type
      • 6.2.5.3.2. By Dosage Form
      • 6.2.5.3.3. By Disease Type
      • 6.2.5.3.4. By Application
      • 6.2.5.4. France
      • 6.2.5.4.1. By Product Type
      • 6.2.5.4.2. By Dosage Form
      • 6.2.5.4.3. By Disease Type
      • 6.2.5.4.4. By Application
      • 6.2.5.5. Spain
      • 6.2.5.5.1. By Product Type
      • 6.2.5.5.2. By Dosage Form
      • 6.2.5.5.3. By Disease Type
      • 6.2.5.5.4. By Application
      • 6.2.5.6. Belgium
      • 6.2.5.6.1. By Product Type
      • 6.2.5.6.2. By Dosage Form
      • 6.2.5.6.3. By Disease Type
      • 6.2.5.6.4. By Application
      • 6.2.5.7. Russia
      • 6.2.5.7.1. By Product Type
      • 6.2.5.7.2. By Dosage Form
      • 6.2.5.7.3. By Disease Type
      • 6.2.5.7.4. By Application
      • 6.2.5.8. The Netherlands
      • 6.2.5.8.1. By Product Type
      • 6.2.5.8.2. By Dosage Form
      • 6.2.5.8.3. By Disease Type
      • 6.2.5.8.4. By Application
      • 6.2.5.9. Rest of Europe
      • 6.2.5.9.1. By Product Type
      • 6.2.5.9.2. By Dosage Form
      • 6.2.5.9.3. By Disease Type
      • 6.2.5.9.4. By Application

7. Asia-Pacific Poultry Vaccines Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Billion)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Dosage Form
    • 7.2.3. By Disease Type
    • 7.2.4. By Application
    • 7.2.5. By Country
      • 7.2.5.1. China
      • 7.2.5.1.1. By Product Type
      • 7.2.5.1.2. By Dosage Form
      • 7.2.5.1.3. By Disease Type
      • 7.2.5.1.4. By Application
      • 7.2.5.2. India
      • 7.2.5.2.1. By Product Type
      • 7.2.5.2.2. By Dosage Form
      • 7.2.5.2.3. By Disease Type
      • 7.2.5.2.4. By Application
      • 7.2.5.3. Japan
      • 7.2.5.3.1. By Product Type
      • 7.2.5.3.2. By Dosage Form
      • 7.2.5.3.3. By Disease Type
      • 7.2.5.3.4. By Application
      • 7.2.5.4. South Korea
      • 7.2.5.4.1. By Product Type
      • 7.2.5.4.2. By Dosage Form
      • 7.2.5.4.3. By Disease Type
      • 7.2.5.4.4. By Application
      • 7.2.5.5. Australia & New Zealand
      • 7.2.5.5.1. By Product Type
      • 7.2.5.5.2. By Dosage Form
      • 7.2.5.5.3. By Disease Type
      • 7.2.5.5.4. By Application
      • 7.2.5.6. Indonesia
      • 7.2.5.6.1. By Product Type
      • 7.2.5.6.2. By Dosage Form
      • 7.2.5.6.3. By Disease Type
      • 7.2.5.6.4. By Application
      • 7.2.5.7. Malaysia
      • 7.2.5.7.1. By Product Type
      • 7.2.5.7.2. By Dosage Form
      • 7.2.5.7.3. By Disease Type
      • 7.2.5.7.4. By Application
      • 7.2.5.8. Singapore
      • 7.2.5.8.1. By Product Type
      • 7.2.5.8.2. By Dosage Form
      • 7.2.5.8.3. By Disease Type
      • 7.2.5.8.4. By Application
      • 7.2.5.9. Vietnam
      • 7.2.5.9.1. By Product Type
      • 7.2.5.9.2. By Dosage Form
      • 7.2.5.9.3. By Disease Type
      • 7.2.5.9.4. By Application
      • 7.2.5.10. Rest of APAC
      • 7.2.5.10.1. By Product Type
      • 7.2.5.10.2. By Dosage Form
      • 7.2.5.10.3. By Disease Type
      • 7.2.5.10.4. By Application

8. Latin America Poultry Vaccines Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Billion)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Dosage Form
    • 8.2.3. By Disease Type
    • 8.2.4. By Application
    • 8.2.5. By Country
      • 8.2.5.1. Brazil
      • 8.2.5.1.1. By Product Type
      • 8.2.5.1.2. By Dosage Form
      • 8.2.5.1.3. By Disease Type
      • 8.2.5.1.4. By Application
      • 8.2.5.2. Mexico
      • 8.2.5.2.1. By Product Type
      • 8.2.5.2.2. By Dosage Form
      • 8.2.5.2.3. By Disease Type
      • 8.2.5.2.4. By Application
      • 8.2.5.3. Argentina
      • 8.2.5.3.1. By Product Type
      • 8.2.5.3.2. By Dosage Form
      • 8.2.5.3.3. By Disease Type
      • 8.2.5.3.4. By Application
      • 8.2.5.4. Peru
      • 8.2.5.4.1. By Product Type
      • 8.2.5.4.2. By Dosage Form
      • 8.2.5.4.3. By Disease Type
      • 8.2.5.4.4. By Application
      • 8.2.5.5. Rest of LATAM
      • 8.2.5.5.1. By Product Type
      • 8.2.5.5.2. By Dosage Form
      • 8.2.5.5.3. By Disease Type
      • 8.2.5.5.4. By Application

9. Middle East & Africa Poultry Vaccines Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Billion)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Dosage Form
    • 9.2.3. By Disease Type
    • 9.2.4. By Application
    • 9.2.5. By Country
      • 9.2.5.1. Saudi Arabia
      • 9.2.5.1.1. By Product Type
      • 9.2.5.1.2. By Dosage Form
      • 9.2.5.1.3. By Disease Type
      • 9.2.5.1.4. By Application
      • 9.2.5.2. UAE
      • 9.2.5.2.1. By Product Type
      • 9.2.5.2.2. By Dosage Form
      • 9.2.5.2.3. By Disease Type
      • 9.2.5.2.4. By Application
      • 9.2.5.3. Qatar
      • 9.2.5.3.1. By Product Type
      • 9.2.5.3.2. By Dosage Form
      • 9.2.5.3.3. By Disease Type
      • 9.2.5.3.4. By Application
      • 9.2.5.4. Kuwait
      • 9.2.5.4.1. By Product Type
      • 9.2.5.4.2. By Dosage Form
      • 9.2.5.4.3. By Disease Type
      • 9.2.5.4.4. By Application
      • 9.2.5.5. South Africa
      • 9.2.5.5.1. By Product Type
      • 9.2.5.5.2. By Dosage Form
      • 9.2.5.5.3. By Disease Type
      • 9.2.5.5.4. By Application
      • 9.2.5.6. Nigeria
      • 9.2.5.6.1. By Product Type
      • 9.2.5.6.2. By Dosage Form
      • 9.2.5.6.3. By Disease Type
      • 9.2.5.6.4. By Application
      • 9.2.5.7. Algeria
      • 9.2.5.7.1. By Product Type
      • 9.2.5.7.2. By Dosage Form
      • 9.2.5.7.3. By Disease Type
      • 9.2.5.7.4. By Application
      • 9.2.5.8. Rest of MEA
      • 9.2.5.8.1. By Product Type
      • 9.2.5.8.2. By Dosage Form
      • 9.2.5.8.3. By Disease Type
      • 9.2.5.8.4. By Application

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Poultry Vaccines Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Poultry Vaccines Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Boehringer Ingelheim International GmbH
  • 12.2. Ceva
  • 12.3. Zoetis
  • 12.4. Elanco
  • 12.5. Merck & Co., Inc.
  • 12.6. Hester Biosciences Limited
  • 12.7. Vaxxinova International BV
  • 12.8. Venkys India
  • 12.9. Calier
  • 12.10. KM Biologics
  • 12.11. Phibro Animal Health Corporation
  • 12.12. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations